CME GroupCME +1.03%90 9-Day RSI is 20.24 as of Jun. 30, 2026. GuruFocus rates CME with a GF Score™ of 90/100 and a GF Value™ of $270.96 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 848 Capital Markets companies, CME Group ranks better than 97.05% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-06-30), CME Group's 9-Day RSI is 20.24.
The industry rank for CME Group's 9-Day RSI or its related term are showing as below:
CME's 9-Day RSI is ranked better than 97.05% of 848
companies
in the Capital Markets industry
Industry Median: 45.485
vs CME: 20.24
CME Group (NAS:CME) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
CME Group 9-Day RSI Related Terms
CME vs MCO, ICE, NDAQ: 9-Day RSI Comparison
For the Financial Data & Stock Exchanges subindustry, CME Group's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group 9-Day RSI vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where CME Group's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME Group (CME) has a 9-Day RSI of 20.24 as of Jun. 30, 2026. According to the industry distribution chart, CME Group ranks #25 out of 848 companies in the Capital Markets industry, placing it in the top 2.9%.
Is CME Group's 9-Day RSI too high?
CME Group's current 9-Day RSI is 20.24. The Capital Markets industry median 9-Day RSI is 45.49. CME Group's value of 20.24 is 55.5% below this industry median. Based on the distribution chart, CME Group ranks #25 out of 848 companies in the Capital Markets industry, which is in the top quartile — a strong position relative to peers. Overall, CME Group has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's 9-Day RSI compare to MCO and ICE?
According to the Capital Markets industry distribution chart, CME Group ranks #25 out of 848 companies for 9-Day RSI. This places CME Group in the top 3% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 45.49. CME Group's value of 20.24 is 55.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Capital Markets company?
The median 9-Day RSI among Capital Markets companies is 45.49, based on 848 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current 9-Day RSI of 20.24 is 55.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Capital Markets industry, the median 9-Day RSI is 45.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current 9-Day RSI is 20.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $270.96, compared to a current price of $220.83 — trading 18.5% below its estimated fair value. The current 9-Day RSI is 20.24 and 55.5% below the Capital Markets industry median of 45.49. CME Group's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For CME Group (CME), the current 9-Day RSI is 20.24 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of $220.83 is trading 18.5% below its estimated GF Value™ of $270.96.
GuruFocus considers CME Group to be Modestly Undervalued.
Key valuation signals for CME:
9-Day RSI: 20.24
GF Value™: $270.96 vs. price of $220.83 (18.5% below fair value)
Industry Position: 55.5% below the Capital Markets median (#25 of 848)
No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
90GF Score
Get the complete analysis for CME
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CME has been successfully added to your 